EBV Infection Clinical Trial
Official title:
A Prospective Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases
This study is a single-center, prospective, observational clinical study to evaluate the Application of saliva EBV-DNA Detection in EBV Infection Related Diseases
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04084626 -
PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
|
Phase 3 | |
Completed |
NCT00711035 -
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06075927 -
Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
|
Phase 1/Phase 2 | |
Recruiting |
NCT05039580 -
Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy
|
Phase 4 | |
Active, not recruiting |
NCT03475212 -
Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation
|
Phase 1/Phase 2 | |
Recruiting |
NCT03159364 -
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04690036 -
PD-1 Antibody for Reactive EBV After BMT
|
Early Phase 1 | |
Recruiting |
NCT03491605 -
Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection
|
||
Recruiting |
NCT04189835 -
EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients
|
||
Recruiting |
NCT04308278 -
Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection
|
Phase 4 | |
Recruiting |
NCT05682703 -
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.
|
||
Completed |
NCT05604378 -
Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis
|
||
Recruiting |
NCT04832607 -
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
|
Phase 3 | |
Recruiting |
NCT06135922 -
Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
|
Phase 1 | |
No longer available |
NCT01945619 -
Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
|
N/A |